Detection of relapse in ovarian cancer by PET-FDG;Detección de recidiva en cáncer de ovario mediante PET-FDG

Revista Espanola de Medicina Nuclear

Volumn 20, Issue 2, 2001, Pages 128-129

  Jimenez Bonilla J ^a   Moya Garcia F ^a   Zomeno Rodriguez M ^a   Ordovas Oromendia A ^a   Konsvintseva, O ^a   Martin Jorge R ^a   Maldonado Suarez A ^a  

^a Instituto Tecnologico PET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RELAPSE; CASE REPORT; FEMALE; HUMAN; LIVER METASTASIS; OVARY CANCER; POSITRON EMISSION TOMOGRAPHY; SPLENOMEGALY; COMPUTER ASSISTED TOMOGRAPHY; CYSTADENOCARCINOMA; METASTASIS; MULTIMODALITY CANCER THERAPY; OVARIECTOMY; OVARY TUMOR; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING; SPLEEN TUMOR;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, SEROUS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; OVARIAN NEOPLASMS; OVARIECTOMY; RADIOPHARMACEUTICALS; SPLENIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035318129     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/S0212-6982(01)71940-4     Document Type: Article

References (2)

1. Wang PH, Liu RS, Li YF, Ng HT, Yuan CC. Whole-Body PET with (Fluorine-18)-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: an initial report. Gynecol Oncol 2000;77(1):44-7.
2. Trampal C, Maldonado A, Sancho F, Morales S, Lluch A, Señor C, et al. Papel de la PET en la sospecha de recidiva tumoral ante la elevación sérica de marcadores tumorales. Rev. Esp. Med. Nuclear 2000;19(4):279-87.